Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
3.740
+0.020 (0.54%)
At close: Oct 31, 2025, 4:00 PM EDT
3.840
+0.100 (2.67%)
After-hours: Oct 31, 2025, 6:33 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $641.68 million as of October 31, 2025. Its market cap has increased by 144.18% in one year.
Market Cap
641.68M
Enterprise Value
550.64M
1-Year Change
144.18%
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $641.68M, an increase of 47.40%. That is a compound annual growth rate of 8.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 638.25M | 219.92% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 450.37B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |